Cargando…
BRCA1/2 testing rates in epithelial ovarian cancer: a focus on the untested patients
BACKGROUND: Since 2015, Dutch guidelines have recommended BRCA1/2 pathogenic variant testing for all patients with epithelial ovarian cancer. Recently, recommendations shifted from germline testing to the tumor-first approach, in which tumor tissue is tested first, and subsequent germline testing is...
Autores principales: | Lanjouw, Lieke, Mourits, Marian J E, Bart, Joost, ter Elst, Arja, Berger, Lieke P V, van der Hout, Annemieke H, Alam, Naufil, de Bock, Geertruida H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423510/ https://www.ncbi.nlm.nih.gov/pubmed/37137525 http://dx.doi.org/10.1136/ijgc-2023-004307 |
Ejemplares similares
-
The Effect of Risk-Reducing Salpingo-Oophorectomy on Breast Cancer Incidence and Histopathological Features in Women with a BRCA1 or BRCA2 Germline Pathogenic Variant
por: Stuursma, Annechien, et al.
Publicado: (2023) -
Proposed legislation supports an untested publishing model
por: Held, Michael J.
Publicado: (2003) -
Daith Piercing: Wonder Treatment or Untested Fad?
por: Bhandari, Priyanka, et al.
Publicado: (2020) -
Aptamers Against COVID-19: An Untested Opportunity
por: Haberland, Annekathrin, et al.
Publicado: (2022) -
Untested assumptions perpetuate stereotyping: Learning in the absence of evidence
por: Cox, William T.L., et al.
Publicado: (2022)